The 16 references in paper V. Lemeshko A., N. Musina Z., V. Fedyaeva K., В. Лемешко А., Н. Мусина З., В. Федяева К. (2018) “СОВЕРШЕНСТВОВАНИЕ ПОДХОДОВ К ЦЕНОВОМУ РЕГУЛИРОВАНИЮ ИННОВАЦИОННЫХ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ, ФИНАНСИРУЕМЫХ ЗА СЧЕТ БЮДЖЕТНЫХ СРЕДСТВ // IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET” / spz:neicon:pharmacoeconomics:y:2017:i:4:p:25-30

1
The pharmaceutical industry and global health: fact and figures
(check this in PDF content)
2
17 [Byulleten’ mezhdunarodnoi Federatsii farmatsevticheskikh proizvoditelei i assotsiatsii (in Russian)]. URL: http://www.ifpma.org/ wp-content/uploads/2017/02/IFPMA-Facts-And-Figures-2017.pdf. Data obrashcheniya: 05.03.2017. 2. Khonl T. A. Problemy ucheta i finansov (in Russian). 2013; 2 (10): 52-54. URL: http://cyberleninka.ru/article/n/zatraty-na-razrabotkuinnovatsionnogo-lekarstvennogo-preparata. Accessed: 05.03.2017.
(check this in PDF content)
3
Akhmetov A. E. Vestnik RUDN. Seriya Ekonomika (in Russian). 2012; 2: 39-45. URL: http://journals.rudn.ru/economics/article/ viewFile/12009/11439. Accessed: 05.03.2017.
(check this in PDF content)
4
Yakunina A. V. Nauka i obshchestvo (in Russian). 2014; 3 (18): 19-26.
(check this in PDF content)
5
Bel’skikh I. E., Kulagina S. V. Mezhdunarodnyi bukhgalterskii uchet (in Russian). 2011; 14 (164): 38-45.
(check this in PDF content)
6
Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research. WHO 2015. URL: http://apps.who.int/medicinedocs/documents/s21793en/ s21793en.pdf. Accessed: 05.03.2017.
(check this in PDF content)
7
WHO guideline on country pharmaceutical pricing policies. WHO 2015. URL: http://apps.who.int/medicinedocs/documents/ s21016en/s21016en.pdf. Accessed: 05.03.2017.
(check this in PDF content)
8
Huttin C. Chapter 8: Experiences with reference pricing. Drugs Money – Prices Affordabil. Cost Contain. Part II Sel. Exp. Policy Options [Internet]. World Health Organization; 2003. URL: http://apps.who.int/ medicinedocs/en/d/Js4912e/3.3.html#Js4912e.3.3. Accessed: 10.03.2017.
(check this in PDF content)
9
Access to medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research World Health Organisation, March 2015 URL: http://apps.who.int/ medicinedocs/documents/s21793en/s21793en.pdf. Accessed: 05.03.2017.
(check this in PDF content)
10
Omel’yanovskii V. V., Sura M. V., Sveshnikova N. D. Pediatricheskaya farmakologiya (in Russian). 2011; 4: 30-35.
(check this in PDF content)
11
Multi-Indication Pricing: Pros, Cons and Applicability to the UK. URL: https://www.slideshare.net/OHENews/multiindication-pricing-proscons-and-applicability-to-the-uk-64621749. Accessed: 05.03.2017.
(check this in PDF content)
12
Sussex J., Towse A., Devlin N. Operationalizing value-based pricing of medicines. Pharmacoeconomics. 2013; 31 (1): 1-10.
(check this in PDF content)
13
Dzhalalov S. Ch., Dzhalalova D. Kh., Khoch D. S. Meditsinskie tekhnologii. Otsenka i vybor (in Russian). 2013; 1 (11): 63-69.
(check this in PDF content)
14
Resolution of the Government of the Russian Federation on October 29, 2010 No. 865 “On state regulation of prices for LP, included in the list of vital and most important LPs” (ed. 03.02.2016) [Postanovlenie Pravitel’stva RF 29 oktyabrya 2010 g. No 865 «O gosudarstvennom regulirovanii tsen na LP, vklyuchennye v perechen’ zhiznenno neobkhodimykh i vazhneishikh LP» (red. ot 03.02.2016) (in Russian)].
(check this in PDF content)
15
Resolution of the Government of the Russian Federation of September 15, 2015 No 979 “On Amendments to the Resolution of the Government of the Russian Federation of October 29, 2010 No. 865 and on the approval of the calculation methodology set by the LP producers of the maximum selling prices for LPs included in the list of vital and essential LP, at their state registration and re-registration” [Postanovlenie Pravitel’stva RF ot 15.09.2015 No 979 «O vnesenii izmenenii v postanovlenie Pravitel’stva Rossiiskoi Federatsii ot 29 oktyabrya 2010 g. No 865 i ob utverzhdenii metodiki rascheta, ustanavlivaemykh proizvoditelyami LP predel’nykh otpusknykh tsen na LP, vklyuchennye v perechen’ zhiznenno neobkhodimykh i vaz
(check this in PDF content)
16
Fedyaev D. V., Maksimova L. V., Omel’yanovskii V. V. Meditsinskie tekhnologii. Otsenka i vybor (in Russian). 2014; 1: 57-64. Сведения об авторах: Лемешко Валерия Александровна – специалист отдела методологического обеспечения проведения комплексной оценки технологий в здравоохранении ФГБУ «Центр экспертизы и контроля качества медицинской помощи» Минздрава России. Адрес: Хохловский пер., д. 10, стр. 5, Москва, Россия, 109028.
(check this in PDF content)